Annual long term liabilities:
$2.22B+$477.48M(+27.36%)Summary
- As of today (September 13, 2025), BBIO annual total long term liabilities is $2.22 billion, with the most recent change of +$477.48 million (+27.36%) on December 31, 2024.
- During the last 3 years, BBIO annual long term liabilities has risen by +$479.25 million (+27.49%).
- BBIO annual long term liabilities is now at all-time high.
Performance
BBIO Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$2.68B+$314.56M(+13.28%)Summary
- As of today (September 13, 2025), BBIO quarterly total long term liabilities is $2.68 billion, with the most recent change of +$314.56 million (+13.28%) on June 30, 2025.
- Over the past year, BBIO quarterly long term liabilities has increased by +$940.65 million (+54.00%).
- BBIO quarterly long term liabilities is now at all-time high.
Performance
BBIO quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
BBIO Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.4% | +54.0% |
| 3 y3 years | +27.5% | +54.5% |
| 5 y5 years | +2231.7% | +10000.0% |
BBIO Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +27.5% | at high | +54.5% |
| 5 y | 5-year | at high | +2231.7% | at high | >+9999.0% |
| alltime | all time | at high | +3940.8% | at high | >+9999.0% |
BBIO Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $2.68B(+13.3%) |
| Mar 2025 | - | $2.37B(+6.6%) |
| Dec 2024 | $2.22B(+27.4%) | $2.22B(+27.4%) |
| Sep 2024 | - | $1.74B(+0.1%) |
| Jun 2024 | - | $1.74B(-0.1%) |
| Mar 2024 | - | $1.74B(-0.0%) |
| Dec 2023 | $1.75B(-0.1%) | $1.75B(+0.1%) |
| Sep 2023 | - | $1.74B(-0.0%) |
| Jun 2023 | - | $1.74B(+0.0%) |
| Mar 2023 | - | $1.74B(-0.2%) |
| Dec 2022 | $1.75B(+0.2%) | $1.75B(+0.4%) |
| Sep 2022 | - | $1.74B(+0.2%) |
| Jun 2022 | - | $1.74B(-0.8%) |
| Mar 2022 | - | $1.75B(+0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $1.74B(+248.6%) | $1.74B(+22.6%) |
| Sep 2021 | - | $1.42B(+1.2%) |
| Jun 2021 | - | $1.41B(+1.3%) |
| Mar 2021 | - | $1.39B(+177.3%) |
| Dec 2020 | $500.05M(+424.6%) | $500.05M(+3612.6%) |
| Sep 2020 | - | $13.47M(+43.3%) |
| Jun 2020 | - | $9.40M(-98.0%) |
| Mar 2020 | - | $472.81M(+396.0%) |
| Dec 2019 | $95.32M(+73.3%) | $95.32M(+24.8%) |
| Sep 2019 | - | $76.41M(-86.2%) |
| Jun 2019 | - | $554.39M(+903.6%) |
| Mar 2019 | - | $55.24M(+0.4%) |
| Dec 2018 | $55.00M(-61.9%) | $55.00M |
| Dec 2017 | $144.18M | - |
FAQ
- What is BridgeBio Pharma, Inc. annual total long term liabilities?
- What is the all time high annual long term liabilities for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. annual long term liabilities year-on-year change?
- What is BridgeBio Pharma, Inc. quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. quarterly long term liabilities year-on-year change?
What is BridgeBio Pharma, Inc. annual total long term liabilities?
The current annual long term liabilities of BBIO is $2.22B
What is the all time high annual long term liabilities for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high annual total long term liabilities is $2.22B
What is BridgeBio Pharma, Inc. annual long term liabilities year-on-year change?
Over the past year, BBIO annual total long term liabilities has changed by +$477.48M (+27.36%)
What is BridgeBio Pharma, Inc. quarterly total long term liabilities?
The current quarterly long term liabilities of BBIO is $2.68B
What is the all time high quarterly long term liabilities for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high quarterly total long term liabilities is $2.68B
What is BridgeBio Pharma, Inc. quarterly long term liabilities year-on-year change?
Over the past year, BBIO quarterly total long term liabilities has changed by +$940.65M (+54.00%)